Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma C Bastiancich, P Danhier, V Préat, F Danhier Journal of Controlled Release 243, 29-42, 2016 | 243 | 2016 |
Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection C Bastiancich, J Bianco, K Vanvarenberg, B Ucakar, N Joudiou, B Gallez, ... Journal of controlled release 264, 45-54, 2017 | 135 | 2017 |
Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma C Bastiancich, K Vanvarenberg, B Ucakar, M Pitorre, G Bastiat, F Lagarce, ... Journal of controlled release 225, 283-293, 2016 | 123 | 2016 |
Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma LP Ganipineni, B Ucakar, N Joudiou, J Bianco, P Danhier, M Zhao, ... International journal of nanomedicine, 4509-4521, 2018 | 89 | 2018 |
On glioblastoma and the search for a cure: where do we stand? J Bianco, C Bastiancich, A Jankovski, A Des Rieux, V Préat, F Danhier Cellular and Molecular Life Sciences 74, 2451-2466, 2017 | 80 | 2017 |
Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival M Zhao, F Danhier, C Bastiancich, N Joudiou, LP Ganipineni, N Tsakiris, ... International journal of pharmaceutics 548 (1), 522-529, 2018 | 71 | 2018 |
In vitro enhanced skin permeation and retention of imiquimod loaded in β-cyclodextrin nanosponge hydrogel M Argenziano, A Haimhoffer, C Bastiancich, L Jicsinszky, F Caldera, ... Pharmaceutics 11 (3), 138, 2019 | 63 | 2019 |
Gemcitabine and glioblastoma: challenges and current perspectives C Bastiancich, G Bastiat, F Lagarce Drug discovery today 23 (2), 416-423, 2018 | 61 | 2018 |
Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells F Joris, L De Backer, T Van de Vyver, C Bastiancich, SC De Smedt, ... Journal of Controlled Release 269, 266-276, 2018 | 59 | 2018 |
Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment C Bastiancich, E Bozzato, U Luyten, F Danhier, G Bastiat, V Préat International journal of pharmaceutics 559, 220-227, 2019 | 57 | 2019 |
Rationally designed drug delivery systems for the local treatment of resected glioblastoma C Bastiancich, A Malfanti, V Préat, R Rahman Advanced drug delivery reviews 177, 113951, 2021 | 54 | 2021 |
Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models C Bastiancich, L Lemaire, J Bianco, F Franconi, F Danhier, V Préat, ... Nanomedicine 13 (16), 1999-2013, 2018 | 43 | 2018 |
Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice J Bianco, C Bastiancich, N Joudiou, B Gallez, A Des Rieux, F Danhier Journal of neuroscience methods 284, 96-102, 2017 | 42 | 2017 |
Photothermal therapy for the treatment of glioblastoma: potential and preclinical challenges C Bastiancich, A Da Silva, MA Estève Frontiers in Oncology 10, 610356, 2021 | 39 | 2021 |
Acyclovir-loaded sulfobutyl ether-β-cyclodextrin decorated chitosan nanodroplets for the local treatment of HSV-2 infections M Donalisio, M Argenziano, M Rittà, C Bastiancich, A Civra, D Lembo, ... International Journal of Pharmaceutics 587, 119676, 2020 | 33 | 2020 |
Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review C Bastiancich, E Bozzato, I Henley, B Newland Journal of Controlled Release 337, 296-305, 2021 | 31 | 2021 |
Enhanced antimicrobial and antibiofilm effect of new colistin-loaded human albumin nanoparticles S Scutera, M Argenziano, R Sparti, F Bessone, G Bianco, C Bastiancich, ... Antibiotics 10 (1), 57, 2021 | 31 | 2021 |
Nanomedicine: A useful tool against glioma stem cells E Bozzato, C Bastiancich, V Préat Cancers 13 (1), 9, 2020 | 23 | 2020 |
New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models A Lopes, C Bastiancich, M Bausart, S Ligot, L Lambricht, K Vanvarenberg, ... Journal for immunotherapy of cancer 9 (4), 2021 | 21 | 2021 |
PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study S Brunato, F Mastrotto, F Bellato, C Bastiancich, A Travanut, M Garofalo, ... Journal of Controlled Release 335, 21-37, 2021 | 18 | 2021 |